How Are European Biotechs Tackling the Cardiovascular Disease Problem?
Cardiovascular diseases may not regularly grab the headlines, but they’re the leading cause of mortality…
Cardiovascular diseases may not regularly grab the headlines, but they’re the leading cause of mortality…
Update (11/03/2020): In a record first, Carmat announced today that one patient in its artificial…
Paris may attract tourist masses, but it also attracts a lot of biotech enthusiasts. In…
Carmat's artificial heart is being tested in patients with heart failure. A hospital in Copenhagen will…
Here's a closer look at the French biotech ecosystem in 2017, which remains one the…
This artificial heart could replace any defective heart. It's being developed by the French company…
Carmat (France) has raised €50M from private investors (dwarfing its 2015's €3M reserves) in order…
There have been some truly amazing Med-tech developments this year, each sounding like they're right…
So preliminary trial results look good - it could be that the next phase will go…
CARMAT intends to overcome the well-known shortfall in heart transplants for the tens of thousands…
The first intelligent artificial heart has been twice implanted in France within clinical trials. It has…